Research and Clinical Trial Information

Many of Nebology products have been hand-chosen for use in clinical trials and studies. Throughout our site, you may see certain products marked as "Clinically Proven" - these are products that have been tested and proven within the clinical trial format. For more information on various clinical trials that include our products, view the various links below. Each is a current or completed study that uses one of the products we sell. At Nebology, we believe in the science of clinically proven products. We want to take the guesswork out of choosing your respiratory therapy equipment. Trust us to help you!

 

Clinical Trial Information Links

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

Study Evaluating Inhaled AeroLEF Delivered in 4 Aerosol Delivery Devices in Healthy Volunteers

The Effects Of Methacholine Challenge Administered Using Three Different Nebulizers On Small Airways Function

A Study in Adult and Pediatric Patients With Cystic Fibrosis

Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age (in process)

Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis (in process)

Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (in process)


Clinical Abstracts and Summaries

A Survey of Patients’ View of Home Nebulizer Treatment for Chronic Lung Disease

Assessment of the new jet nebulizer platform PARI LC® SPRINT designed for different age groups and a faster delivery of aqueous inhalation formulations

In Vitro Delivery of Budesonide from 30 Jet Nebulizer Compressor Combinations Using Infant and Child Breathing Patterns

In Vitro Determination of Inhaled Mass and Particle Distribution of Budesonide Nebulizing Suspension Particle Distribution of Budesonide

Nebulizers offer COPD patients improved quality of life

Are there differences in throat deposition using variable valved holding chambers?

Comparison of Nebulized Drug Delivery Times of Four Nebulizers

Efficacy of Battery Powered Portable Nebulizer Systems using Albuterol

Efficacy of Portable Nebulizer Systems using Budesonide

Evaluation of Three Devices and One Technique for Pulmonary Drainage in a CF Patient

Facial and Ocular Deposition of Nebulized Budesonide – Effects of Facemask Design, AARC

Facial and Ocular Deposition of Nebulized Budesonide – Effects of Facemask Design, ATS

In vitro Comparison of Lung Delivery of Xopenex and Flovent HFA using Vortex and AeroChamber Plus Holding Chambers

Inhalation therapy with jet nebulisers – conventional but not old fashioned!

Location of Facemask Vents, Facial Deposition, and Drug Delivery During Wet Nebulization

 

Our products have been chosen to test product by the following companies:

Clinical Company Logos